Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

As Drug Value Frameworks Gain Traction, Patients Seek More Input

Executive Summary

'Patients are ready and willing to have conversations' about trade-offs, National Health Council's Perfetto says.

Advertisement

Related Content

Patients’ View Of Drug Value Is Focus Of Avalere/FasterCures Framework
Drug Pricing: With "Value" Debate In Full Swing, ICER’s Influence Grows
ICER Eyes QALY Ratios, Budget Impacts In Methods Review
Oncology Drug Value Tools From NCCN, ASCO To Get Real-World Testing
Scoring Value: New Tools Challenge Pharma's US Pricing Bonanza
‘DrugAbacus’ Pricing Tool Helps Payers Calculate Fair Value Of Cancer Drugs

Topics

Advertisement
UsernamePublicRestriction

Register

PS119214

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel